Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Mild to Moderate Alzheimer Disease”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)Looking for participantsNCT07633470
What this trial is testing

Zunveyl on Safety, Tolerability, Neuropsychiatric Symptoms, and Caregiver Distress in Alzheimer's Disease (RESOLVE)

Who this might be right for
Alzheimer Disease
Alpha Cognition, Inc 150
Not applicableStudy completedNCT07548073
What this trial is testing

Effect of Scene-Based Training on Cognitive Function in Patients With Alzheimer's Disease

Who this might be right for
Alzheimer DiseaseCognitive DysfunctionMild Cognitive Impairment
Zhejiang Provincial Tongde Hospital 126
Not applicableStudy completedNCT00467766
What this trial is testing

Combining a Caregiver Intervention With Aricept Treatment for Mild to Moderate Alzheimer's Disease

Who this might be right for
Alzheimer DiseaseCaregivers
Pfizer 300
Testing effectiveness (Phase 2)UnknownNCT03790982
What this trial is testing

Evaluate the Safety and Efficacy of AD-35 Tablet in Subjects With Mild to Moderate Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Zhejiang Hisun Pharmaceutical Co. Ltd. 240
Large-scale testing (Phase 3)Study completedNCT02017340
What this trial is testing

A Phase III Trial of Nilvadipine to Treat Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Prof Brian Lawlor 511
Large-scale testing (Phase 3)Ended earlyNCT00550420
What this trial is testing

Study Of Rosiglitazone XR In Subjects With Mild-to-Moderate Alzheimers

Who this might be right for
Alzheimer's Disease
GlaxoSmithKline 331
Testing effectiveness (Phase 2)Study completedNCT00141661
What this trial is testing

A Safety and Tolerability Evaluation of Two 10-Week Dose Regimens of Orally-Administered PF-04494700 in Alzheimer's Patients

Who this might be right for
Alzheimer Disease
Pfizer 67
Post-approval studies (Phase 4)Study completedNCT00202124
What this trial is testing

Double Blind Study of Trp01 in Patients With Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Queen's University 12
Not applicableLooking for participantsNCT04124029
What this trial is testing

Contributions of mTBI to Neurodegeneration Due to Chronic Traumatic Encephalopathy (CTE) and Alzheimer's Disease (AD)

Who this might be right for
Mild Traumatic Brain InjuryModerate Traumatic Brain InjuryMild Cognitive Impairment
VA Office of Research and Development 800
Testing effectiveness (Phase 2)Study completedNCT00093951
What this trial is testing

SGS742 in Patients With Mild to Moderate Alzheimer's Disease (AD)

Who this might be right for
Alzheimer's Disease
Saegis Pharmaceuticals 280
Testing effectiveness (Phase 2)Study completedNCT02249403
What this trial is testing

Efficacy and Safety of Talsaclidine in Patients With Mild to Moderate Dementia of Alzheimer Type

Who this might be right for
Alzheimer Disease
Boehringer Ingelheim 362
Testing effectiveness (Phase 2)Study completedNCT01354691
What this trial is testing

Safety and Efficacy Study of Ladostigil in Mild to Moderate Probable Alzheimer's Disease

Who this might be right for
Alzheimer's DiseaseDementiaMemory Loss+1 more
Avraham Pharmaceuticals Ltd 200
Testing effectiveness (Phase 2)UnknownNCT05578443
What this trial is testing

Efficacy, Safety and Response Predictors of Astragalus Membranaceus on the Improvement of Cognitive Function in Mild-to-Moderate Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Fujian Medical University Union Hospital 66
Testing effectiveness (Phase 2)UnknownNCT00606164
What this trial is testing

Safety, Efficacy, Pharmacokinetics, and Pharmacodynamics Study of Bryostatin 1 in Patients With Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Blanchette Rockefeller Neurosciences Insitute 9
Testing effectiveness (Phase 2)Study completedNCT01723826
What this trial is testing

A Long-Term Safety Extension of Studies ABE4869g and ABE4955g in Participants With Mild to Moderate Alzheimer's Disease Treated With Crenezumab

Who this might be right for
Alzheimer's Disease
Genentech, Inc. 360
Testing effectiveness (Phase 2)Study completedNCT02756858
What this trial is testing

An Extension Study of ANAVEX2-73 in Patients With Mild to Moderate Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Anavex Life Sciences Corp. 21
Not applicableLooking for participantsNCT05295615
What this trial is testing

Pulsed Electromagnetic Field Treatment In Patients With Alzheimer's Disease

Who this might be right for
Alzheimer Disease
Herrick Medical LLC 40
Early research (Phase 1)Study completedNCT02353598
What this trial is testing

Crenezumab in Participants With Mild to Moderate Alzheimer Disease

Who this might be right for
Alzheimer Disease
Genentech, Inc. 77
Testing effectiveness (Phase 2)Study completedNCT02947893
What this trial is testing

Impact of Nilotinib on Safety, Biomarkers and Clinical Outcomes in Mild to Moderate Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Georgetown University 37
Testing effectiveness (Phase 2)Study completedNCT05363293
What this trial is testing

Multiple Ascending Dose Safety, Tolerability, PK Study of AL001 in Alzheimer's Disease Patients & Healthy Adult Subjects

Who this might be right for
Alzheimer's DiseaseHealthy Non-elderly and Elderly Adults
Alzamend Neuro, Inc. 65
Next Page